Trials / Unknown
UnknownNCT04984928
Readmission Risk of Patients With Heart Failure.
Predicting the Risk of Readmission in Patients With Chronic Heart Failure
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Heart failure (HF) is a frequent, serious, and costly chronic disease: it leads to 150,000 hospitalizations each year in France at a cost of 525 million Euros. It is estimated that 20-40% of these hospitalizations are preventable by known interventions: home telemonitoring, care coordination, therapeutic intensification and therapeutic education. But these interventions only work if patients at high risk of rehospitalization are targeted to individualize management. In these patients, the risk of rehospitalization depends on clinical, biological, socioeconomic, care pathway, and location-related data. Existing predictive tools perform poorly due to three important limitations: non-use of unstructured clinical data, lack of integration of multimodal data, and weakness of the algorithmic approach. The objective is to design and validate a predictive algorithm for the risk of rehospitalization in heart failure patients, using multiple data sources
Conditions
Timeline
- Start date
- 2021-09-20
- Primary completion
- 2022-12-01
- Completion
- 2022-12-30
- First posted
- 2021-08-02
- Last updated
- 2022-04-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04984928. Inclusion in this directory is not an endorsement.